| Alzheimer's disease: targeting the cholinergic system T H Ferreira-Vieira, I M Guimaraes, F R Silva, F M Ribeiro Current neuropharmacology 14 (1), 101-115, 2016 | 1481 | 2016 |
| Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors IG Olmo, TG Carvalho, VV Costa, J Alves-Silva, CZ Ferrari, ... Frontiers in immunology 8, 1016, 2017 | 93 | 2017 |
| Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide JA Jackman, VV Costa, S Park, ALCV Real, JH Park, PL Cardozo, ... Nature Materials 17 (11), 971-977, 2018 | 84 | 2018 |
| N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection VV Costa, JL Del Sarto, RF Rocha, FR Silva, JG Doria, IG Olmo, ... MBio 8 (2), 10.1128/mbio. 00350-17, 2017 | 79 | 2017 |
| Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease FM Ribeiro, RA DeVries, A Hamilton, IM Guimaraes, SP Cregan, ... Human molecular genetics 23 (8), 2030-2042, 2014 | 61 | 2014 |
| The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease JG Doria, JM de Souza, JN Andrade, HA Rodrigues, IM Guimaraes, ... Neurobiology of disease 73, 163-173, 2015 | 60 | 2015 |
| The metabotropic glutamate receptor 5 role on motor behavior involves specific neural substrates IM Guimaraes, TG Carvalho, SSG Ferguson, GS Pereira, FM Ribeiro Molecular brain 8, 1-13, 2015 | 39 | 2015 |
| N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease FR Silva, AS Miranda, RPM Santos, IG Olmo, GW Zamponi, T Dobransky, ... Neurobiology of aging 55, 1-10, 2017 | 31 | 2017 |
| Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington’s disease FM Ribeiro, A Hamilton, JG Doria, IM Guimaraes, SP Cregan, ... Expert opinion on therapeutic targets 18 (11), 1293-1304, 2014 | 29 | 2014 |
| NVP-BEZ235 (Dactolisib) has protective effects in a transgenic mouse model of Alzheimer’s disease PMQ Bellozi, GF Gomes, LR De Oliveira, IG Olmo, ÉLM Vieira, FM Ribeiro, ... Frontiers in pharmacology 10, 1345, 2019 | 27 | 2019 |
| Dissecting the signaling pathways involved in the crosstalk between metabotropic glutamate 5 and cannabinoid type 1 receptors IG Olmo, TH Ferreira-Vieira, FM Ribeiro Molecular Pharmacology 90 (5), 609-619, 2016 | 26 | 2016 |
| Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of CaV1 Channels AS Miranda, PL Cardozo, FR Silva, JM de Souza, IG Olmo, JS Cruz, ... ASN neuro 11, 1759091419856811, 2019 | 23 | 2019 |
| The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease JG Doria, JM de Souza, FR Silva, IG Olmo, TG Carvalho, J Alves‐Silva, ... Journal of neurochemistry 147 (2), 222-239, 2018 | 22 | 2018 |
| N-Methyl-D-aspartate (NMDA) receptor blockade prevents neuronal death induced by Zika virus infection. mBio 8: e00350-17 VV Costa, JL Del Sarto, RF Rocha, FR Silva, JG Doria, IG Olmo, ... | 11 | 2017 |
| Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors. Front Immunol 8: 1016 IG Olmo, TG Carvalho, VV Costa, J Alves-Silva, CZ Ferrari, ... | 9 | 2017 |
| High-throughput sequencing of BACHD mice reveals upregulation of neuroprotective miRNAs at the pre-symptomatic stage of Huntington’s disease IG Olmo, RP Olmo, ANA Gonçalves, RGW Pires, JT Marques, FM Ribeiro ASN neuro 13, 17590914211009857, 2021 | 8 | 2021 |
| 7-Deaza-7-fluoro-2′-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation JL Del Sarto, RPF Rocha, L Bassit, IG Olmo, B Valiate, CM Queiroz-Junior, ... Antiviral Research 180, 104855, 2020 | 8 | 2020 |
| Estradiol effect on short-term object memory under hypocholinergic condition LM Pereira, IM Guimarães, VEM Oliveira, CP Bastos, FM Ribeiro, ... Brain research bulletin 140, 411-417, 2018 | 6 | 2018 |
| Role of dynein axonemal heavy chain 6 gene expression as a possible biomarker for Huntington’s disease: a translational study LB Areal, LP Pereira, FM Ribeiro, IG Olmo, MR Muniz, ... Journal of Molecular Neuroscience 63, 342-348, 2017 | 6 | 2017 |
| mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington’s disease phenotype JM de Souza, TH Ferreira-Vieira, EMA Maciel, NC Silva, IBQ Lima, ... Scientific Reports 12 (1), 8982, 2022 | 4 | 2022 |
